Results 271 to 280 of about 1,648,291 (376)

Risk of cardiac, neuropsychiatric and musculoskeletal adverse events with levothyroxine: Systematic review

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Abstract Levothyroxine (LT4) is the standard treatment for hypothyroidism and the most widely prescribed medication worldwide. Although generally safe, regulatory reports list potential cardiac, neuropsychiatric and musculoskeletal adverse events (AEs). Clarifying their clinical relevance is essential.
Bala Swetha Baskaran   +2 more
wiley   +1 more source

Comparison of thyroid function tests in alopecia totalis and universalis with control group

open access: green, 2013
Hassan Seirafi   +5 more
openalex   +1 more source

CHANGING IN THYROID FUNCTION TEST IN CHILDREN UNDERWENT ANTIEPILEPTIC THERAPY [PDF]

open access: green, 2010
Ahmad Talebian   +5 more
openalex   +1 more source

Clinical Images: Methotrexate‐induced melanonychia

open access: yes
Arthritis &Rheumatology, EarlyView.
Yoshinori Taniguchi, Hirotaka Yamamoto
wiley   +1 more source

Treatment of patients with prolactinomas [PDF]

open access: yes, 1978
Fahlbusch, R.   +5 more
core   +1 more source

Cold atmospheric plasma‐mediated tumor microenvironment remodeling for cancer treatment

open access: yesBMEMat, EarlyView.
Schematic presentation of CAP‐mediated TME remodeling. This review summarizes recent efforts in cold atmospheric plasma (CAP) application in cancer treatment, highlighting the anticancer potential of CAP, molecular mechanisms, and future perspectives for further improvement and clinical translation.
Israr Khan   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy